Somatic Health and Kinetisense are launching a cutting edge clinical study in partnership with Rothman Orthopaedics to ...

The decades-long research effort has contributed to thousands of research papers, altering medical care for women around the ...

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company ...

The sarcopenia market remains largely untapped, with significant unmet medical needs and no approved drug therapies in major markets. As global demographics shift toward older populations, ...

Evestia Clinical - the new brand identity for EMAS Pharma - launches  as a market leading pharmaceutical research  specialist focussed on Clinical Trials in Oncology and Rare  Diseases.Letchworth ...

In this video interview, Rob Jones, product manager, TMF practice area, Pharmalex, discusses how risk-based approaches must be prioritized amidst the increased demand for quality and compliance.

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

The first Nexalin device has been shipped to São Paulo, Brazil, with additional units and single-use disposable electrodes scheduled for delivery in the coming days. These shipments support the launch ...

Syncona Limited Mosaic Therapeutics in-licences two clinical-stage assets from Astex Pharmaceuticals In-licensing these clinical-stage assets has significantly de-risked and accelerated Mosaic’s ...

As scientific interest in psychedelic-assisted therapies continues to surge, MindScape Retreat, a licensed Ibogaine treatment facility located on the peaceful island of Cozumel, ...

IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, today unveiled new findings from its EVIDENCE-RM study¹. Leveraging extensive data from the French National ...